Sector: In Vitro And In Vivo Diagnostic Substances Region: Norway

: | Oslo Exchange: MEDI

MediStim ASA engages in the development, manufacturing and distribution of medical equipment and consumables. It operates through the following segments: Lease of equipment within cardiac surgery, Capital and consumable sales within cardiac surgery, Sales of electronic stethoscopes, and Distribution and sales of third party products. The Lease of equipment within cardiac surgery segment delivers system and probes at the customer site without free of charge. The Capital and consumable sales within cardiac surgery segment is based upon the same products as within lease of equipment within cardiac surgery. The Sales of electronic stethoscopes segment represents the part of the business that was acquired by Meditron ASA and merged with MediStim. The Distribution and sales of third party products segment sells third party products in the markets where it has direct representation. The company was founded by Kari Mette Tjlsen Pah on June 10, 1984 and is headquartered in Oslo, Norway.


Kari Eian Krogstad, President and CEO
Kari E. Krogstad joined MediStim on September 1st 2009. Krogstad holds a M.Sc. degree in Molecular Biology from the University of Oslo as well as a Business degree from IHM Business School. She has 20 years of experience from the biomedical industry, from commercial roles within the pharma, biotech and medtech sectors. Krogstad has held senior leadership positions within marketing, sales, business development and general management in Nycomed and Dynal. Before joining MediStim, she spent 11 years at Dynal, where she lead Invitrogen Dynal in the role as General Manager after the acquisition from Invitrogen in 2005.
Thomas Jakobsen, CFO
Thomas Jakobsen joined MediStim as VP Finance in 2001. Previous experience includes Controller and Finance Manager at Sysdeco (1993-1998), and Finance Director of Microtronica Nordic (1998-2001), where he was responsible for building the finance team and converting to a new MIS system. Thomas has a key role in the finance and business development of MediStim. Thomas holds a B.Sc. in Management from the Norwegian School of Management.

News & Analysis